Chien-Ling Huang

Regenerative approaches to post-myocardial infarction heart failure.

N. Caplice, Kenneth Martin, Chien-Ling Huang, 2014, Current pharmaceutical design.

Disabled-2 Is Required for Efficient Hemostasis and Platelet Activation by Thrombin in Mice

C. Tseng, Hui-Ju Tsai, J. Cooper, 2014, Arteriosclerosis, thrombosis, and vascular biology.

Rapid detection and identification of clinically important bacteria by high-resolution melting analysis after broad-range ribosomal RNA real-time PCR.

C. Tseng, Yi-Chih Chang, Shy-Shin Chang, 2006, Clinical chemistry.

Synthetic chemically modified mrna-based delivery of cytoprotective factor promotes early cardiomyocyte survival post-acute myocardial infarction.

D. Whelan, A. Leblond, Arun H. S. Kumar, 2015, Molecular pharmaceutics.

Disabled-2 is a novel αIIb-integrin-binding protein that negatively regulates platelet-fibrinogen interactions and platelet aggregation

C. Tseng, J. Hsieh, A. Stern, 2006, Journal of Cell Science.

A novel CX3CR1 antagonist eluting stent reduces stenosis by targeting inflammation.

S. Pierrou, Arun H. S. Kumar, N. Caplice, 2015, Biomaterials.

Intravascular cell delivery device for therapeutic VEGF-induced angiogenesis in chronic vascular occlusion.

E. Ritman, S. Russell, K. Skelding, 2014, Biomaterials.

Rapid detection of glucose-6-phosphate dehydrogenase gene mutations by denaturing high-performance liquid chromatography.

C. Tseng, D. Chiu, K. Chong, 2005, Clinical biochemistry.